Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, has announced it will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, 2024 at 7:30 a.m. Central Time. Interested participants can pre-register for the call through a provided link to receive call information. The conference call will also be webcast and accessible via Baxter's website at www.baxter.com. Baxter has noted that the call will be recorded and is copyrighted material, prohibiting unauthorized recording or rebroadcasting without the company's permission.
Baxter International Inc. (NYSE:BAX), un leader globale nel settore medtech, ha annunciato che ospiterà una conferenza telefonica per discutere i propri risultati finanziari del terzo trimestre 2024 venerdì 8 novembre 2024 alle 7:30 ora centrale. I partecipanti interessati possono preregistrarsi per la chiamata attraverso un link fornito per ricevere informazioni sulla chiamata. La conferenza telefonica sarà anche trasmessa in diretta e accessibile tramite il sito web di Baxter all'indirizzo www.baxter.com. Baxter ha fatto sapere che la chiamata sarà registrata ed è materiale protetto da copyright, vietando registrazioni o riproduzioni non autorizzate senza il permesso dell'azienda.
Baxter International Inc. (NYSE:BAX), un líder global en tecnología médica, ha anunciado que llevará a cabo una llamada conferencia para discutir sus resultados financieros del tercer trimestre de 2024 el viernes 8 de noviembre de 2024 a las 7:30 a.m. hora central. Los participantes interesados pueden preinscribirse para la llamada a través de un enlace proporcionado para recibir información sobre la llamada. La conferencia también se transmitirá en vivo y será accesible a través del sitio web de Baxter en www.baxter.com. Baxter ha señalado que la llamada será grabada y es material protegido por derechos de autor, prohibiendo grabaciones o retransmisiones no autorizadas sin el permiso de la empresa.
Baxter International Inc. (NYSE:BAX), 세계적인 메드텍 기업,은 2024년 3분기 재무 결과에 대해 논의하기 위해 2024년 11월 8일 금요일 오전 7:30 중앙 시간에 컨퍼런스 콜을 개최한다고 발표했습니다. 관심 있는 참가자는 제공된 링크를 통해 전화를 사전 등록하여 전화 정보를 받을 수 있습니다. 이 컨퍼런스 콜은 웹캐스트되며 Baxter의 웹사이트 www.baxter.com를 통해 접근 가능합니다. Baxter는 이 전화 통화가 녹음되며 저작권 있는 자료로, 회사의 허가 없이 무단으로 녹음하거나 재전송하는 것을 금지한다고 밝혔습니다.
Baxter International Inc. (NYSE:BAX), un leader mondial en technologie médicale, a annoncé qu'il tiendra une conférence téléphonique pour discuter de ses résultats financiers du troisième trimestre 2024 le vendredi 8 novembre 2024 à 7h30, heure centrale. Les participants intéressés peuvent préenregistrer leur participation via un lien fourni pour recevoir des informations sur l'appel. La conférence sera également diffusée en direct et accessible via le site web de Baxter à l'adresse www.baxter.com. Baxter a noté que l'appel sera enregistré et est une œuvre protégée par des droits d'auteur, interdisant toute enregistrement ou rediffusion non autorisée sans la permission de l'entreprise.
Baxter International Inc. (NYSE:BAX), ein globaler führender Medizintechnikanbieter, hat angekündigt, dass es eine Telefonkonferenz abhalten wird, um über seine Finanzergebnisse des dritten Quartals 2024 zu diskutieren am Freitag, den 8. November 2024 um 7:30 Uhr Central Time. Interessierte Teilnehmer können sich über einen bereitgestellten Link für die Konferenz registrieren, um Informationen zur Konferenz zu erhalten. Die Telefonkonferenz wird auch live übertragen und über die Website von Baxter unter www.baxter.com zugänglich sein. Baxter hat darauf hingewiesen, dass die Konferenz aufgezeichnet wird und urheberrechtlich geschütztes Material ist, das eine unautorisierte Aufnahme oder Wiederübertragung ohne Genehmigung des Unternehmens verbietet.
- None.
- None.
This call is also being webcast and can be accessed through Baxter’s website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission.
About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241016475593/en/
Media Contact
Steve Brett, (224) 948-5353
media@baxter.com
Investor Contact
Clare Trachtman, (224) 948-3020
Source: Baxter International Inc.
FAQ
When will Baxter (BAX) release its Q3 2024 financial results?
How can investors participate in Baxter's (BAX) Q3 2024 earnings call?
Is Baxter's (BAX) Q3 2024 earnings call available for later viewing or listening?
